Detalhe da pesquisa
1.
Guillain-Barré syndrome is infrequent among recipients of the BNT162b2 mRNA COVID-19 vaccine.
Clin Immunol;
230: 108818, 2021 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34358692